Literature DB >> 4451820

Transport of taurine by normal human blood platelets.

L Ahtee, D J Boullin, M K Paasonen.   

Abstract

1 Because normal human blood platelets contain higher concentrations of taurine than any other amino acid, and have a platelet: plasma concentration gradient exceeding 400: 1, we isolated the cells in vitro and incubated them with radioactively labelled taurine in order to investigate the existence of a metabolically-dependent accumulation process.2 Platelets incubated with taurine (1 to 100 nmol/ml) in autologous plasma or Krebs solution accumulated [(14)C]-taurine against the concentration gradient.3 The transport process was saturable at high concentrations, showed a requirement for sodium ions, and was temperature-dependent.4 The kinetics of transport fulfilled the criteria of Michaelis & Menten for saturable enzyme/substrate interactions, but the kinetic constants were influenced by the incubation medium.5 The metabolic inhibitors 2,4-dinitrophenol and iodoacetic acid in combination inhibited taurine transport in Krebs solution, but stimulated transport in autologous plasma. The latter result suggested the involvement of a sodium-dependent ATPase in taurine transport.6 We conclude that platelets actively transport taurine in vitro under experimental conditions closely resembling those likely to occur in vivo, and that this taurine transport process may be involved in the maintenance of the platelet: plasma concentration gradient.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451820      PMCID: PMC1776876          DOI: 10.1111/j.1476-5381.1974.tb09707.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  On the adenosine triphosphatase activity of rat brain mitochondria.

Authors:  R TANAKA; L G ABOOD
Journal:  J Biol Chem       Date:  1962-09       Impact factor: 5.157

2.  Taurine in human blood platelets.

Authors:  J FRENDO; A KOJ; J M ZGLICZYNSKI
Journal:  Nature       Date:  1959-03-07       Impact factor: 49.962

3.  The accumulation and metabolism of dopamine by the human platelet.

Authors:  H M Solomon; N M Spirt; W B Abrams
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

4.  Protein synthesis by human blood platelets after accumulation of leucine and arginine.

Authors:  D J Boullin; M Votavova; A R Green
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

5.  The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices.

Authors:  D F Bogdanski; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

6.  Subcellular distribution of taurine and cysteinesulphinate decarboxylase in developing rat brain.

Authors:  H C Agrawal; A N Davison; L K Kaczmarek
Journal:  Biochem J       Date:  1971-05       Impact factor: 3.857

7.  Na+ -dependent transport in the intestine and other animal tissues.

Authors:  R K Crane
Journal:  Fed Proc       Date:  1965 Sep-Oct

8.  Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPA.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  The accumulation of guanethidine by human blood platelets.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

10.  Mechanisms by which human blood platelets accumulate glycine, gaba and amino acid precursors of putative neurotransmitters.

Authors:  D J Boullin; A R Green
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

View more
  9 in total

1.  Plasma and whole blood taurine concentrations respond differently to taurine supplementation (humans) and depletion (cats).

Authors:  E A Trautwein; K C Hayes
Journal:  Z Ernahrungswiss       Date:  1995-06

2.  Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

Authors:  L M Starling; D J Boullin; D G Grahame-Smith; C B Adams; R S Gye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

3.  Characterization of a carrier-mediated transport system for taurine in the fetal mouse heart in vitro.

Authors:  D S Grosso; W R Roeske; R Bressler
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Differential adriamycin distribution to blood components.

Authors:  T Colombo; M Broggini; S Garattini; M G Donelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).

Authors:  B Hartley-Asp; P I Christensson; K Gunnarsson; P O Gunnarsson; G Jensen; J Polacek; A Stamvik
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

6.  Studies on retinitis pigmentosa in man. I. Taurine and blood platelets.

Authors:  M J Voaden; A A Hussain; I P Chan
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

7.  Transport of taurine and its regulation by protein kinase C in the JAR human placental choriocarcinoma cell line.

Authors:  P Kulanthaivel; D R Cool; S Ramamoorthy; V B Mahesh; F H Leibach; V Ganapathy
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

Review 8.  Taurine and Its Derivatives: Analysis of the Inhibitory Effect on Platelet Function and Their Antithrombotic Potential.

Authors:  Adrian Eugen Roşca; Ana-Maria Vlădăreanu; Radu Mirica; Cristina-Mihaela Anghel-Timaru; Alina Mititelu; Bogdan Ovidiu Popescu; Constantin Căruntu; Suzana Elena Voiculescu; Şerban Gologan; Minodora Onisâi; Iuliana Iordan; Leon Zăgrean
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

9.  Impact of Prolonged Blood Incubation and Extended Serum Storage at Room Temperature on the Human Serum Metabolome.

Authors:  Beate Kamlage; Sebastian Neuber; Bianca Bethan; Sandra González Maldonado; Antje Wagner-Golbs; Erik Peter; Oliver Schmitz; Philipp Schatz
Journal:  Metabolites       Date:  2018-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.